Wheeler et al., 1999 - Google Patents
Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor: a role for serines 426 and 427 in regulating …Wheeler et al., 1999
View HTML- Document ID
- 16934777268414194915
- Author
- Wheeler M
- Gelling R
- Hinke S
- Tu B
- Pederson R
- Lynn F
- Ehses J
- McIntosh C
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone involved in the regulation of insulin secretion. In non-insulin-dependent diabetes mellitus insulin responses to GIP are blunted, possibly due to altered signal transduction or reduced …
- 102100000695 GIP 0 title abstract description 52
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Culhane et al. | Transmembrane signal transduction by peptide hormones via family BG protein-coupled receptors | |
Willard et al. | Physiology and emerging biochemistry of the glucagon‐like peptide‐1 receptor | |
Liu et al. | Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport | |
Wheeler et al. | Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor: a role for serines 426 and 427 in regulating the rate of internalization | |
Elshourbagy et al. | Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor | |
Aiyar et al. | A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor (∗) | |
Gardella et al. | Molecular properties of the PTH/PTHrP receptor | |
Hinuma et al. | New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals | |
Day et al. | A new glucagon and GLP-1 co-agonist eliminates obesity in rodents | |
Juaneda et al. | The molecular pharmacology of CGRP and related peptide receptor subtypes | |
Ersoy et al. | Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR | |
Shimizu et al. | Parathyroid hormone (PTH)-(1–14) and-(1–11) analogs conformationally constrained by α-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor | |
Hudson et al. | Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs | |
Runge et al. | Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus | |
Blad et al. | Biological and pharmacological roles of HCA receptors | |
Elshourbagy et al. | Molecular cloning and characterization of the porcine calcitonin gene-related peptide receptor | |
Haugaard-Kedstrom et al. | Solution structure, aggregation behavior, and flexibility of human relaxin-2 | |
Darbalaei et al. | Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors | |
Fang et al. | The influence of peptide context on signaling and trafficking of glucagon-like peptide-1 receptor biased agonists | |
Yaqub et al. | Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand | |
Unson et al. | Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling | |
Fortin et al. | Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function | |
Ferrari et al. | Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′, 5′-monophosphate signaling by β-arrestin2 | |
Park et al. | A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates | |
Cerdá-Reverter et al. | Involvement of melanocortin receptor accessory proteins (MRAPs) in the function of melanocortin receptors |